Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: December 2018

12/6/2018 RNC Pharma Database Update: Pharmaceutical Drug Production in Russia (October 2018)

Between January and October 2018, Russia produced 276.2 mln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 1.9% higher than that of the same period of 2017. The positive dynamics are mostly due to the active work of manufacturers. In physicals terms though, Russia produced 3.3 bln units of pharmaceuticals, which is 9.4% lower than that of the same period of 2017.